IFLScience on MSN
First Targeted Treatment For Dangerous Liver Disease Could Come From An Unexpected Source
Scientists could be on course to develop the first treatment with a chance of controlling and even reversing liver fibrosis, ...
TipRanks on MSN
Akeso and TransThera Sciences Launch Promising Phase II Study for Advanced Liver Cancer
Inc. are conducting an open-label, multicenter Phase II clinical study titled An Open-label, Multicenter, Phase II C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results